Document ID: chunk:federal_register_of_legislation:F2017L00467:reg:9:p3
Version: federal_register_of_legislation:F2017L00467
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 8797–10784

the two years before the clinical worsening of bronchiectasis;
(33)      having allergic bronchopulmonary aspergillosis at the time of the clinical worsening of bronchiectasis;
Note: allergic bronchopulmonary aspergillosis is defined in the Schedule 1 - Dictionary.
(34)      undergoing solid organ or bone marrow transplantation before the clinical worsening of bronchiectasis;
(35)      having fibrosis or fibrosing interstitial lung disease, involving the segment of the lung affected by bronchiectasis, before the clinical worsening of bronchiectasis;
(36)      being exposed to arsenic as specified before the clinical worsening of bronchiectasis;
Note: being exposed to arsenic as specified is defined in the Schedule 1 - Dictionary.
(37)      having a disease from the specified list of connective tissue diseases at the time of the clinical worsening of bronchiectasis;
Note: specified list of connective tissue diseases is defined in the Schedule 1 - Dictionary.
(38)      being infected with human immunodeficiency virus before the clinical worsening of bronchiectasis;
(39)      having a haematological malignancy at the time of the clinical worsening of bronchiectasis;
(40)      being treated with an immunosuppressive drug within the five years before the clinical worsening of bronchiectasis;
Note: immunosuppressive drug is defined in the Schedule 1 - Dictionary.
(41)      being infected with human T-cell lymphotropic virus type 1 before the clinical worsening of bronchiectasis;
(42)      having inflammatory bowel disease at the time of the clinical worsening of bronchiectasis;
(43)      having severe and persistent asthma within the five years before the clinical worsening of bronchiectasis;
Note: severe and persistent asthma is defined in the Schedule 1 - Dictionary.
(44)      having chronic obstructive pulmonary disease at the time of the clinical worsening of bronchiectasis;
(45)      inability to obtain appropriate clinical management for bronchiectasis.